Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
24.4%
% of GNOM's 41 holdings also in IDNA
22.2%
% of IDNA's 49 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in GNOM |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
BIONTECH SE SPONSORED ADR | 4.1% | 5.0% | 4.1% | |
SAREPTA THERAPEUTICS INC | 3.6% | 4.2% | 3.6% | |
BEAM THERAPEUTICS, INC. | 3.6% | 2.5% | 2.5% | |
GILEAD SCIENCES INC | 2.0% | 5.9% | 2.0% | |
MODERNA, INC. | 3.0% | 1.2% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to IDNA
ENI SPA-SPONSORED ADR | 7.7% | |
NATERA INC | 5.4% | |
VERACYTE INC | 5.1% | |
ARROWHEAD PHARMACEUTICALS, INC. | 4.2% | |
BIO-TECHNE CORPORATION | 4.2% | |
QIAGEN NV | 4.2% | |
AGILENT TECHNOLOGIES INC | 4.0% | |
ILLUMINA INC | 3.8% | |
BIOMARIN PHARMACEUTICAL INC | 3.6% | |
ULTRAGENYX PHARMACEUTICAL IN | 3.2% |
GNOM Underweight Relative to IDNA
EXELIXIS INC | -6.7% | |
INCYTE CORP | -4.9% | |
BEIGENE, LTD. | -4.8% | |
REVOLUTION MEDICINES, INC. | -4.7% | |
ROCHE HOLDING LTD | -4.4% | |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% | |
SANOFI-AVENTIS | -4.0% | |
ARCELLX, INC. | -3.9% | |
GILEAD SCIENCES INC | -3.9% | |
GSK PLC | -3.4% |